PTH and Hypocalcemia: For Pt 8, pharmacological treatment was changed after the detection of TRPM6 variants—i.e., calcium replacement was discontinued and magnesium supplement was increased—because the severe magnesium deficiency caused hypocalcemia secondary to the impaired synthesis and secretion of the parathyroid hormone [17].